*<p>Deaths and survivors at 90 days of follow-up, ignoring censored observations.</p>†<p>Observed mortality at 90-days estimated from Kaplan-Meier curve using all observations within each cell. In total, 3921 patients (26%) were reclassified according to 5vMELD (in cells with ≥20 observations); 3591 (92%) were correctly reclassified. The reclassification calibration statistic for MELD is 273.2 (<i>P</i><0.0001) vs. 60.0 for 5vMELD (<i>P</i><0.0001). Reclassification improvement with 5vMELD is 7.2% (174−94 of 1113) among deaths and 7.2% (1736 – 955 of 10802) among survivors, leading to a net reclassification improvement of 14.4% (95% CI 11.4 to 17.5%; <i>P</i><0.0001).</p
<p>Risk discrimination was assessed for FINRISK study participants with the risk prediction scores d...
Observed mortality risk (A) at 56 days, (B) during inpatient stay, and (C) post-discharge in the der...
<p>(A) The mean CDRs differed significantly among the three groups (<i>P</i> = 0.024, One-way ANOVA ...
<p>Net Reclassification Index (NRI) = 3.2% (p value 0.08). Patients are categorized into risk catego...
<p>This figure shows mortality in patients classified as “low risk”, “moderate risk” and “high risk”...
<p>CVD = cardiovascular disease; NRI = net reclassification improvement. Conventional cardiovasc...
Abstract Background The risk reclassification table assesses clinical performance of a biomarker in ...
<p>During the study period, the probability of transplantation within 3 months of listing among pati...
<p>Groups of predicted risk were made with approximately equal numbers of death using Restricted Ind...
<p>(A) Patients who died despite low MELD scores would have had the largest increase in points had a...
We have previously proposed temporal recalibration to account for trends in survival over time to im...
In this supplement, we provide R code to estimate the net reclassification improvement (NRI) in the ...
<p>Abbreviations: FRS = Framingham Risk Score, KM = Kaplan Meier</p><p>This table shows the distribu...
<p>Abbreviations: FRS = Framingham Risk Score, KM = Kaplan Meier</p><p>This table shows the distribu...
<p>Kaplan-Meier survival curve censoring deaths before day 90 of follow-up (end point of the RENAL S...
<p>Risk discrimination was assessed for FINRISK study participants with the risk prediction scores d...
Observed mortality risk (A) at 56 days, (B) during inpatient stay, and (C) post-discharge in the der...
<p>(A) The mean CDRs differed significantly among the three groups (<i>P</i> = 0.024, One-way ANOVA ...
<p>Net Reclassification Index (NRI) = 3.2% (p value 0.08). Patients are categorized into risk catego...
<p>This figure shows mortality in patients classified as “low risk”, “moderate risk” and “high risk”...
<p>CVD = cardiovascular disease; NRI = net reclassification improvement. Conventional cardiovasc...
Abstract Background The risk reclassification table assesses clinical performance of a biomarker in ...
<p>During the study period, the probability of transplantation within 3 months of listing among pati...
<p>Groups of predicted risk were made with approximately equal numbers of death using Restricted Ind...
<p>(A) Patients who died despite low MELD scores would have had the largest increase in points had a...
We have previously proposed temporal recalibration to account for trends in survival over time to im...
In this supplement, we provide R code to estimate the net reclassification improvement (NRI) in the ...
<p>Abbreviations: FRS = Framingham Risk Score, KM = Kaplan Meier</p><p>This table shows the distribu...
<p>Abbreviations: FRS = Framingham Risk Score, KM = Kaplan Meier</p><p>This table shows the distribu...
<p>Kaplan-Meier survival curve censoring deaths before day 90 of follow-up (end point of the RENAL S...
<p>Risk discrimination was assessed for FINRISK study participants with the risk prediction scores d...
Observed mortality risk (A) at 56 days, (B) during inpatient stay, and (C) post-discharge in the der...
<p>(A) The mean CDRs differed significantly among the three groups (<i>P</i> = 0.024, One-way ANOVA ...